Search

everythinglearnresearchcommunity

for

Search:↓

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

Albendazole can cause hair loss, and piroxicam can cause fixed drug eruption.

Tirzepatide may improve hair loss by reducing insulin resistance.

Antibody treatments show promise for hair loss but need more research.

A man developed a unique rash on his neck after taking niacinamide, and doctors recommend considering niacinamide as a cause for similar rashes and using dermatoscopy for diagnosis.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

Tofacitinib may help treat hair loss in children with alopecia areata.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

Infliximab may cause hair loss in Crohn's disease patients.

CD8+ T cells attack hair follicle stem cells, causing scarring and hair loss.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

QR678 Neo® improved seborrheic dermatitis symptoms in a small group of patients.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

Denosumab may cause alopecia areata.

Certain medications can cause serious side effects, so it's important to report them.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

New micelle solutions greatly improve skin delivery of certain antifungal drugs.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

JAK inhibitors are effective treatments for alopecia areata.

Negative expectations can cause adverse effects in dermatology treatments, like with finasteride for baldness, and careful communication can help reduce these nocebo responses.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.